- Research works
- 0 fractional, all time
- Citations
- 4 9.5 per fractional work
- Top-10% rate
- 59.5% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Immune Biosolutions (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Immune Biosolutions (Canada) publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, COVID-19 Clinical Research Studies and Chemical Synthesis and Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 2 Long-Term Effects of COVID-19 Neurology 0 works
- 3 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 4 Chemical Synthesis and Analysis Molecular Biology 0 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 6 Receptor Mechanisms and Signaling Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Sherbrooke
- Université de Sherbrooke
- Bishop's University
- Centre Hospitalier Universitaire de Sherbrooke
- Health and Social Services Centre University Institute of Geriatrics of Sherbrooke
- Institut interdisciplinaire d'innovation technologique
- Champlain Regional College
- Cégep de Sherbrooke
- Hôpital Fleurimont
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.